DreamCIS

DreamCIS Gross Margin

The Gross Margin of DreamCIS (223250.KQ) as of Nov 5, 2026 is 29.08 %. In the previous year, Gross Margin was 30.45 % — a change of -4.51% (lower).

Gross Margin

29.08 %

YoY

-4.51%

Last updated:

Gross Margin of DreamCIS is 2025 29.08 % . Gross Margin of DreamCIS was 2024 30.45 % . It decreases by -4.51% lower compared to the previous year.

DreamCIS's gross margin stands at 29.1%, down from 33.2% several years earlier.

The DreamCIS Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
35.91 KRW
Jan 1, 2019
37.99 KRW
Jan 1, 2020
40.94 KRW
Jan 1, 2021
33.23 KRW
Jan 1, 2022
35.67 KRW
Jan 1, 2023
27.04 KRW
Jan 1, 2024
30.45 KRW
Jan 1, 2025
29.08 KRW
The DreamCIS Gross Margin history
YEARGross MarginYoY
29.08 %-4.51%
30.45 %+12.61%
27.04 %-24.18%
35.67 %+7.33%
33.23 %-18.83%
40.94 %+7.76%
37.99 %+5.81%
35.91 %+144.97%
14.66 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DreamCIS Stock analysis

What does DreamCIS do? DreamCIS Inc. is a company based in Seoul, South Korea, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company went public on May 22, 2020, with its stock listed under the ticker 223250.KQ and ISIN KR7223250002. DreamCIS Inc. provides clinical online information and consultation services, focusing on regulatory post-marketing surveillance (rPMS), clinical trials, and non-interventional studies (NIS). The company serves both domestic and international markets, offering its services to clients seeking support in clinical research and regulatory compliance. Its headquarters are located in Seoul, South Korea. The company's website is http://www.dreamcis.com/, which serves as a primary source for further information about its services and operations. DreamCIS Inc. does not provide detailed information about its founding year, specific leadership, or financial figures beyond its IPO date, and no acquisitions or additional product names are mentioned in the provided data. The company's services are primarily aimed at facilitating clinical research and ensuring adherence to regulatory standards in the life sciences sector. DreamCIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DreamCIS stock

Gross Margin of DreamCIS is 29.08 % in 2025.

Gross Margin of DreamCIS changed from 30.45 % to 29.08 %, representing a -4.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin DreamCIS since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's DreamCIS with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — DreamCIS

All Key Metrics — DreamCIS